USPTO serial 87121316
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rodney L. Skoglund
RODNEY L. SKOGLUND RENNER KENNER GREIVE BOBAK TAYLOR & WEBER106 SOUTH MAIN STREETFIRST NATIONAL TOWER, SUITE 400AKRON, OH 44308| Class | Description | Status | First use |
|---|---|---|---|
| 005 | (Based on 44(e)) (Based on Intent to Use) pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders; (Based on Intent to Use) Pharmaceutical and veterinary preparations and substances for the treatment of cardiovascular disorders, central nervous system disorders, acute and chronic pain, epilepsy, insomnia, learning disorders, infectious diseases, gastrointestinal diseases, diabetes, impotence, obesity, skin disorders, host-graft rejections, arthritis and autoimmune disorders | ACTIVE | — |
| 042 | (Based on 44(e)) (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; medical research relating to the diagnosis and treatment of disease involving the use of pharmaceutical and veterinary preparations and substances allowing for controlled absorption and/or controlled release of an active ingredient following administration to human and non-human animals and based on liquid emulsion drug delivery systems; (Based on Intent to Use) Scientific and biological research relating to the research and development of pharmaceutical and veterinary preparations and substances; medical research relating to the diagnosis and treatment of disease; medical research on the efficacy of pharmaceutical and veterinary preparations and substances; medical and scientific research, namely, conducting clinical trials involving pharmaceutical and veterinary preparations and substances | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 4, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 4, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jun 9, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 7, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 7, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 7, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 2, 2018 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 7, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 7, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 18, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 3, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 29, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 22, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Sep 15, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Sep 13, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 11, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 11, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 11, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 11, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 10, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 10, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 8, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 8, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 10, 2017 | ALIE | ASSIGNED TO LIE | — |
| Mar 27, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 15, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 15, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 15, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 3, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 2, 2016 | NWAP | NEW APPLICATION ENTERED | — |